ICU Medical Income from Discontinued Operations 2010-2025 | ICUI

ICU Medical income from discontinued operations from 2010 to 2025. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
ICU Medical Annual Income from Discontinued Operations
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
ICU Medical Quarterly Income from Discontinued Operations
(Millions of US $)
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.175B $2.382B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $218.924B 25.68
Boston Scientific (BSX) United States $159.425B 38.08
Stryker (SYK) United States $153.031B 32.00
EssilorLuxottica (ESLOY) France $136.054B 0.00
Medtronic (MDT) Ireland $118.007B 16.73
Lonza Group Ag (LZAGY) Switzerland $50.909B 0.00
Haleon (HLN) United Kingdom $43.800B 25.00
ResMed (RMD) United States $40.084B 30.11
GE HealthCare Technologies (GEHC) United States $35.372B 16.79
Agilent Technologies (A) United States $33.937B 22.12
Terumo (TRUMY) Japan $25.318B 32.88
Koninklijke Philips (PHG) Netherlands $24.891B 17.47
Insulet (PODD) United States $20.174B 79.19
Zimmer Biomet Holdings (ZBH) United States $19.257B 12.37
Baxter (BAX) United States $14.656B 10.94
Smith & Nephew SNATS (SNN) United Kingdom $13.945B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.996B 24.34
Lantheus Holdings (LNTH) United States $5.072B 12.79
Perrigo (PRGO) Ireland $3.866B 9.80
Prestige Consumer Healthcare (PBH) United States $3.792B 16.94
Haemonetics (HAE) United States $3.582B 16.32
Envista Holdings (NVST) United States $3.517B 29.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
LeMaitre Vascular (LMAT) United States $1.856B 41.49
QuidelOrtho (QDEL) United States $1.799B 12.37
AtriCure (ATRC) United States $1.526B 0.00
Acuren (TIC) United States $1.435B 0.00
AdaptHealth (AHCO) United States $1.301B 13.20
Green Thumb Industries (GTBIF) United States $1.217B 27.38
Phibro Animal Health (PAHC) United States $1.208B 15.44
Neogen (NEOG) United States $1.098B 14.06
BioLife Solutions (BLFS) United States $1.074B 0.00
InMode (INMD) Israel $0.944B 9.51
Kestra Medical Technologies (KMTS) United States $0.859B 0.00
Curaleaf Holdings (CURLF) Canada $0.838B 0.00
Tilray Brands (TLRY) Canada $0.741B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.667B 0.00
Owens & Minor (OMI) United States $0.637B 5.28
Valneva SE (VALN) France $0.622B 0.00
Evolus (EOLS) United States $0.618B 0.00
CeriBell (CBLL) United States $0.569B 0.00
ZimVie (ZIMV) United States $0.523B 23.77
Surmodics (SRDX) United States $0.464B 0.00
SNDL (SNDL) Canada $0.420B 0.00
VAREX IMAGING (VREX) United States $0.317B 11.65
Sanuwave Health (SNWV) United States $0.315B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.314B 0.00
Capricor Therapeutics (CAPR) United States $0.312B 0.00
Cresco Labs (CRLBF) United States $0.298B 0.00
Quanterix (QTRX) United States $0.284B 0.00
Cerus (CERS) United States $0.277B 0.00
Aurora Cannabis (ACB) Canada $0.274B 81.33
Viemed Healthcare (VMD) United States $0.255B 21.53
OraSure Technologies (OSUR) United States $0.247B 0.00
Sanara MedTech (SMTI) United States $0.243B 0.00
Canopy Growth (CGC) Canada $0.240B 0.00
Biote (BTMD) United States $0.232B 6.52
Brainsway (BWAY) Israel $0.225B 59.45
Omeros (OMER) United States $0.224B 0.00
Verano Holdings (VRNOF) United States $0.217B 0.00
Organigram Global (OGI) Canada $0.208B 0.00
High Tide (HITI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.189B 15.39
TriSalus Life Sciences (TLSI) United States $0.178B 0.00
Exagen (XGN) United States $0.156B 0.00
Vireo Growth (VREOF) United States $0.151B 0.00
FitLife Brands (FTLF) United States $0.127B 15.65
TerrAscend (TSNDF) Canada $0.116B 0.00
MacroGenics (MGNX) United States $0.114B 0.00
Jin Medical (ZJYL) China $0.110B 0.00
Safety Shot (SHOT) United States $0.105B 0.00
Fonar (FONR) United States $0.101B 12.98
Quipt Home Medical (QIPT) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Jushi Holdings (JUSHF) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.076B 0.00
Agape ATP (ATPC) $0.074B 0.00
InterCure (INCR) Israel $0.070B 0.00
Cytosorbents (CTSO) United States $0.064B 0.00
ImmuCell (ICCC) United States $0.063B 0.00
United-Guardian (UG) United States $0.044B 15.21
Modular Medical (MODD) United States $0.039B 0.00
Rockwell Medical (RMTI) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.43
Allurion Technologies (ALUR) United States $0.024B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00